Olympus Co. (OTCMKTS:OLYMY – Get Free Report) was the recipient of a large decrease in short interest in July. As of July 31st, there was short interest totaling 17,276 shares, a decrease of 60.1% from the July 15th total of 43,336 shares. Based on an average daily volume of 100,297 shares, the days-to-cover ratio is currently 0.2 days.
Analyst Ratings Changes
Separately, The Goldman Sachs Group cut shares of Olympus from a “buy” rating to a “neutral” rating in a research report on Monday, June 15th. One investment analyst has rated the stock with a Hold rating, Based on data from MarketBeat, the stock presently has a consensus rating of “Hold”.
Get Our Latest Stock Report on OLYMY
Olympus Trading Up 1.5%
Olympus Company Profile
Olympus Corporation is a Tokyo-based manufacturer specializing in precision technology for the medical, scientific and industrial markets. Established in 1919, the company has built an international reputation for optical and digital imaging solutions that encompass endoscopic systems, microscopes, cameras and related accessories. Olympus leverages its expertise in optics, mechanics and electronics to develop instruments designed to advance diagnostics and scientific discovery.
In the healthcare sector, Olympus is best known for its endoscopy products and therapeutic solutions that support minimally invasive procedures in gastroenterology, pulmonology and urology.
Featured Stories
- Five stocks we like better than Olympus
- Is Best Buy the AI Winner Hiding in the Electronics Aisle?
- Applied Materials Beat Everything but Wall Street’s Expectations for Margins
- Back From Orbit, Intuitive Machines’ Share Price Enters the Buy Zone
- Texas Roadhouse and Brinker International Have the Recipe Rivals Are Missing
Receive News & Ratings for Olympus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Olympus and related companies with MarketBeat.com's FREE daily email newsletter.
